Tinnitus

THURSDAY, November 21, 2019
12:15pm— Hope Conference Center
TINNITUS: CLINICAL MANAGEMENT, IMAGING, AND TREATMENT
ROBERT DARFLINGER, MD, INTERVENTIONAL RADIOLOGY, PSJMC
WARREN LINE, JR., MD, DEPARTMENT OF SURGERY, PSJMC
MODERATOR:
Michael Marvi, MD, Department of Medicine, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Line and Darflinger state they have no financial relationships with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 12-06-19
Review Date: 12/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Goals of surgery for degenerative spine disease

THURSDAY, November 14, 2019
12:15pm— Hope Conference Center
GOALS OF SURGERY FOR DEGENERATIVE SPINE DISEASE
JAMES NGUYEN, MD
DEPARTMENT OF SURGERY, PSJMC
MODERATOR: Pablo Lawner, MD, Department of Surgery, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Nguyen states he has no financial relationships with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 12-03-19
Review Date: 12/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Stroke Prevention after ICH

TUESDAY, November 12, 2019
12:15pm – Hope Conference Center
SECONDARY STROKE PREVENTION
NERSES SANOSSIAN, MD, FAHA
ASSOC. PROFESSOR (CLINICAL SCHOLAR); DIR., NEUROCRITICAL CARE & STROKE
DEPARTMENT OF NEUROLOGY, USC
MODERATOR: Lin LeMay, MD, Chair, Neurology Section, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Sanossian states he is on the Speaker’s Bureau for Genentech, consults on the Clinical Events Committees for Clinical Trials for Medtronic and has received grant funding from Diffusion Pharma. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 12-03-19
Review Date: 12/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Estrogen Matters

TUESDAY, October 8, 2019
12:15pm – Hope Conference Center
ESTROGEN MATTERS:
DOES TAKING HORMONES IN MENOPAUSE IMPROVE WOMEN’S WELL-BEING AND LENGTHEN THEIR LIVES?
AVRUM BLUMING, MD
CLINICAL PROFESSOR OF MEDICINE, USC
PLANNER/MODERATOR:
Ora Gordon, MD, Chair, Cancer Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Gordon and Bluming state they have no financial arrangements with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 11-4-19
Review Date: 11/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

SJMC "Active Threat" Considerations

TUESDAY, July 16, 2019
12:15pm – Hope Conference Center
“ACTIVE THREAT” CONSIDERATIONS: DEFINE, PREPARE, RESPOND
LIEUTENANT ADAM CORNILS
BURBANK POLICE DEPARTMENT
PLANNER/MODERATOR: Connie Lackey, RN; Director, Emergency
Preparedness/Safety/Security, PSJMC, PHCMC, PTMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Ms. Lackey and Lt. Cornils state they have no financial arrangements with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 9-24-19
Review Date: 9/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Hypertension Across the Women's Life Cycle

THURSDAY, June 20, 2019
12:15pm, Hope Conference Center
HYPERTENSION ACROSS A WOMAN’S LIFECYCLE
SUSAN CHENG, MD, MMSC, MPH
DIRECTOR OF CARDIOVASCULAR POPULATION SCIENCES
BARBRA STREISAND WOMEN’S HEART CENTER
SMIDT HEART INSTITUTE
DIRECTOR OF PUBLIC HEALTH RESEARCH, CEDARS-SINAI MEDICAL CENTER
PLANNER/MODERATOR:
Daniel Eisenberg, MD; Medical Director, Cardiovascular Services, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Eisenberg and Cheng state they have no financial relationships with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 9-24-19
Review Date: 9/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Pituitary Disorders and Tumors

TUESDAY, June 18, 2019
12:15pm – Hope Conference Center
CURRENT APPROACH TO PITUITARY DISORDERS AND TUMORS GAUTAM MEHTA, MD
DEPARTMENT OF SURGERY, PSJMC
MODERATOR: Lin LeMay, MD; Chair, Neurology Section, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Mehta states he has no financial arrangements with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

This activity satisfies DHS radiology requirements for renewal of fluoroscopy permit.
Release Date: 9-24-19
Review Date: 9/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

BLOOD PRESSURE CONTROL:NOT JUST FOR PREVENTION OF CARDIOVASCULAR DISEASE

TUESDAY, June 11, 2019
12:15pm – Hope Conference Center
BLOOD PRESSURE CONTROL:
NOT JUST FOR PREVENTION OF CARDIOVASCULAR DISEASE
ROGER ON, MD
DEPARTMENT OF MEDICINE, PSJMC
PLANNER/MODERATOR: Nilesh Desai, MD; Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Desai and On state they have no financial arrangements with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 7-5-19
Review Date: 7/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Prehospital Therapy of Stroke

TUESDAY, May 14, 2019
12:15pm – Hope Conference Center
SYSTEMS OF STROKE CARE:
CURRENT CHALLENGES, FUTURE DIRECTIONS NERSES SANOSSIAN, MD, FAHA
ASSOCIATE PROFESSOR, CLINICAL SCHOLAR
DIRECTOR, NEUROCRITICAL CARE & STROKE, USC
PLANNER/MODERATOR:
Lin LeMay, MD; Chair, Neurology Section, PSJMC FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. LeMay states she has no financial arrangements with any commercial company to disclose. Dr. Sanossian discloses he is on the Speakers Bureau for Genentech, Is a consultant on the clinical events committees for clinical trials for Medtronic and has received grant funding from Diffusion Pharma. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 9-24-19
Review Date: 9/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

#BreastImplantIllness

THURSDAY, April 18, 2019
12:15pm, Hope Conference Center
NEW DEVELOPMENTS IN BREAST IMPLANT ILLNESS
LUKACZ SWISTUN, MD
DEPARTMENT OF SURGERY, PSJMC
MODERATOR: Deanna Attai, MD, Department of Surgery, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Swistun states he has no financial relationships with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 7-9-19
Review Date: 7/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Hot Topics in Breast Cancer

TUESDAY, April 16, 2019
12:15pm – Hope Conference Center
WHAT'S TRENDING IN BREAST CANCER?
HOT TOPICS IN THE NEWS AND ON SOCIAL MEDIA
DEANNA ATTAI, MD, FACS
DEPARTMENT OF SURGERY, PSJMC
MODERATOR: Carlie Thompson, MD, Department of Surgery, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Attai states she has no financial arrangements with any commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at

www.providencecme.org.

Click Here For Learning Objectives

Release Date: 7-9-19
Review Date: 7/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

The Path to Personalized Medicine in IBD

TUESDAY, April 9, 2019
12:15pm--Hope Conference Center
THE PATH TO PERSONALIZED MEDICINE IN IBD
DERMOT P.B. MCGOVERN, MD, PHD, MRCP
DIRECTOR, TRANSLATIONAL MEDICINE
F. WIDJAJA FOUNDATION INFLAMMATORY BOWEL AND IMMUNOBIOLOGY RESEARCH
INSTITUTE, CEDARS-SINAI MEDICAL CENTER
PLANNER/MODERATOR:
Ora Gordon, MD, MS; Regional Medical Director, Center for Clinical Genetics & Genomics; Medical Director, Integrative Medicine, Roy and Patricia Disney Family Cancer Center, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Gordon states she has no financial arrangements with any commercial company to disclose. Dr. McGovern discloses he is a consultant for Precision IBD, Gilead, Janssen, Bridge Therapeutics, Qu Biologics, and Pfizer, and has received grant support from Janssen and Second Genome. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Arthritis

THURSDAY, March 21, 2019
12:15pm, Hope Conference Center
ORTHOPEDIC OPTIONS FOR PATIENTS WITH ARTHRITIS
SHAHAB MAHBOUBIAN, DO
DEPARTMENT OF SURGERY, PSJMC
PLANNER/MODERATOR:
Nilesh Desai, MD, Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Desai and Mahboubian state they have no financial relationship with a commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives

This activity satisfies DHS radiology requirements for renewal of fluoroscopy permit.
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Diagnosis and Management of Rheumatoid Arthritis

TUESDAY, March 19, 2019
12:15pm—Hope Conference Center
DIAGNOSIS AND MANAGEMENT OF RHEUMATOID ARTHRITIS
PENG FAN, MD
CLINICAL PROFESSOR OF MEDICINE, DIVISION OF RHEUMATOLOGY
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
PLANNER/MODERATOR:
Nilesh Desai, MD, Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Desai states he has no financial arrangements with any commercial company to disclose. Dr. Fan discloses he is on the Speakers Bureau for Amgen, Novartis, Pfizer, Sanofi, Genzyme, Abbrie, Radius, Regeneron. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Recognition and Management of Osteoarthritis

THURSDAY, March 14, 2019
12:15pm, Hope Conference Center
RECOGNITION AND MANAGEMENT OF OSTEOARTHRITIS
PENG FAN, MD
CLINICAL PROFESSOR OF MEDICINE, DIVISION OF RHEUMATOLOGY
DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
PLANNER/MODERATOR:
Nilesh Desai, MD, Department of Medicine liaison to the Medical Education Committee, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Desai states he has no financial relationship with a commercial company to disclose. Dr. Fan discloses he is on the Speakers Bureau for Amgen, Novartis, Pfizer, Sanofi, Genzyme, Abbrie, Radius, Regeneron. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives

This activity satisfies DHS radiology requirements for renewal of fluoroscopy permit.
Release Date: 5-15-19
Review Date: 5/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Aortic Stenosis

THURSDAY, February 28, 2019
12:15pm, Hope Conference Center
INTERESTING CARDIAC CASES
PRABHDEEP SANDHU, MD
DOUGLAS SCHRECK, MD
DEPARTMENT OF MEDICINE, PSJMC
PLANNER/MODERATOR:
Daniel Eisenberg, MD, Medical Director, Cardiac Services, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Eisenberg, Sandhu, and Schreck state they have no financial relationship with a commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.

Click Here For Learning Objectives

Release Date: 9-24-19
Review Date: 9/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Heart Failure: When to Consider Bridge Devices or Transplantation

TUESDAY, February 26, 2019
HEART FAILURE: WHEN TO CONSIDER BRIDGE DEVICES OR TRANSPLANTATION JON KOBASHIGAWA, MD
DSL/THOMAS D. GORDON CHAIR IN HEART TRANSPLANTATION MEDICINE
CEDARS-SINAI MEDICAL CENTER
PLANNER/MODERATOR:
Daniel Eisenberg, MD, Medical Director, Cardiac Services, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Eisenberg states he has no financial arrangements with any commercial company to disclose. Dr. Kobashigawa states he has received consulting fees from CareDX and research grants from CareDX, Novartis, and Sanofi/Genzyme. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 4-12-19
Review Date: 4/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Rebuilding the Food Pyramid

THURSDAY, February 21, 2019
12:15pm, Hope Conference Center
REBUILDING THE FOOD PYRAMID – DIETARY GUIDELINES FOR AMERICANS
KURT HONG, M.D., PH.D., FACN
DIRECTOR, CENTER FOR CLINICAL NUTRITION & APPLIED HEALTH RESEARCH
KECK HOSPITAL OF USC
PLANNER/MODERATOR:
Daniel Eisenberg, MD, Medical Director, Cardiac Services, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Drs. Eisenberg and Hong state they have no financial relationship with a commercial company to disclose.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Antimicrobial Stewardship: Why the Hospital and SNF should care

TUESDAY, January 22, 2019
12:15pm – Hope Conference Center
ANTIMICROBIAL STEWARDSHIP AFTER HOSPITAL DISCHARGE; WHY THE HOSPITAL AND SKILLED NURSING FACILITY SHOULD CARE
JAMES A. MCKINNELL, M.D.
ASSISTANT PROFESSOR OF MEDICINE, DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA
MODERATOR:
Aric Gregson, MD, infectious disease specialist, PSJMC
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. McKinnell states he is a research consultant for Achaogen, Melinta, Cempra, Thermo Fisher and Allergan; is on the Speakers Bureau for Allergan; and is the founder of Expert Stewardship. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 4-17-19
Review Date: 4/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.

Acute Flaccid Myelitis

THURSDAY, January 10, 2019
12:15pm, Hope Conference Center
UPDATE ON ACUTE FLACCID MYELITIS (AFM)
JAY D. DESAI, M.D.
ASSISTANT PROFESSOR OF CLINICAL NEUROLOGY, USC
MODERATOR:
Michael Marvi, MD; neurology liaison to the PSJMC Medical Education Committee
FACULTY/PLANNER DISCLOSURES:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Desai discloses he has received research funding from Epilepsy Foundation of Greater Los Angeles, Novartis, Neurelis, and UCB. It is our policy to review presentations ahead of time in order to resolve any potential conflicts of interest. No conflicts were identified in the review of today’s presentation.
Disclosures for members of the Medical Education Committee may be found at the CME sign-in desk and on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 4-17-19
Review Date: 4/22
Termination Date:

This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.